ImmunityBio (IBRX) Operating Expenses (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Operating Expenses of $114.0 million for Q1 2026, up 40.83% year-over-year from $80.9 million in Q1 2025, and up 10.71% quarter-over-quarter from $103.0 million in Q4 2025.
ImmunityBio (IBRX) Operating Expenses (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Operating Expenses for 13 consecutive years, with $114.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 40.83% year-over-year to $114.0 million; the TTM figure through Mar 2026 stood at $402.4 million (up 16.75% YoY), while the FY2025 annual figure was $369.3 million, up 2.89% from the prior year.
- Operating Expenses grew to $114.0 million in Q1 2026 per IBRX's latest filing, from $103.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $114.0 million in Q1 2026 and bottomed at $77.0 million in Q4 2024.
- Historically, Operating Expenses has averaged $91.6 million across 5 years, with a median of $87.7 million in 2025.
- Annual changes were most pronounced in 2025 — Operating Expenses decreased 15.0% — and 2026, when it surged 40.83%.
- ImmunityBio's Operating Expenses stood at $85.0 million in 2022, then climbed by 0.65% to $85.5 million in 2023, then fell by 10.03% to $77.0 million in 2024, then soared by 33.81% to $103.0 million in 2025, then increased by 10.71% to $114.0 million in 2026.
- Business Quant data shows IBRX's Operating Expenses at $114.0 million in Q1 2026, $103.0 million in Q4 2025, and $87.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | 112.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.94 Mn |
| Mar 31, 2026 | 114.00 Mn |
| Dec 31, 2025 | 102.97 Mn |
| Sep 30, 2025 | 87.69 Mn |
| Jun 30, 2025 | 97.71 Mn |
| Mar 31, 2025 | 80.95 Mn |
| Dec 31, 2024 | 76.95 Mn |
| Sep 30, 2024 | 86.36 Mn |
| Jun 30, 2024 | 100.38 Mn |
| Mar 31, 2024 | 95.24 Mn |
| Dec 31, 2023 | 85.53 Mn |
| Sep 30, 2023 | 80.22 Mn |
| Jun 30, 2023 | 85.19 Mn |
| Mar 31, 2023 | 111.94 Mn |
| Dec 31, 2022 | 84.97 Mn |
| Sep 30, 2022 | 90.92 Mn |
| Jun 30, 2022 | 79.66 Mn |
| Mar 31, 2022 | 95.99 Mn |
| Dec 31, 2021 | 79.66 Mn |
| Sep 30, 2021 | 78.90 Mn |